"Your browser does not support JavaScript. If the webpage function is not working properly, please enable the browser JavaScript status."
Name-based rapid test distribution system to remain in place until April 30 and be discontinued as of May 1 as it has served its purpose in previous stages of pandemic
2023 - 4
25
Effective May 1, COVID-19 to be downgraded to Category 4 notifiable communicable disease and CECC to disband; Ministry of Health and Welfare to take charge of relevant preparation and response work
Third wave of Omicron infections remains at low point with average of 93 new domestic cases (complications) per day; CECC confirms 102 new cases of Omicron subvariants
20
ACIP experts recommend expanding eligibility for use of Moderna BA.4/BA.5 bivalent COVID-19 vaccine as booster to include children 6 months through age 5 years of age
13
Effective April 17, CECC to adjust some visitation, resident management measures for residential long-term care facilities during COVID-19
Third wave of Omicron infections remains at low point with average of 86 new domestic cases (complications) per day; CECC confirms 36 new cases of Omicron subvariants
CECC revises criteria for release from isolation for confirmed COVID-19 cases (with complications)
7
CECC to expand eligibility for receiving preventative monoclonal antibody medication targeting SARS-CoV-2 and adjust related recommendations based on dominant strains and effectiveness of medication
CECC announces plans to relax mask rules on public transportation; eased rules scheduled to take effect on April 17 if pandemic situation remains stable
CECC to adjust testing measures for inpatients and individuals accompanying patients to hospitals on April 10; other control measures for visitors and individuals accompanying patients remain unchanged